Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack Provides the most potent bactericidal ability that no other PEP antibiotics in ...
It aims to promote strategic collaborations in global while also highlights its many innovative advances and successful scientific ventures. BOSTON and SEOUL, South Korea, May 9, 2022 /PRNewswire/ -- ...
SEOUL, South Korea and BOSTON, May 13, 2025 /PRNewswire/ -- iNtRON Biotechnology, Inc., a biotechnology company focused on developing innovative endolysin-based new biological drug for superbugs and ...
iNtRON stated that following the proprietary development of the Robot Bacteriophage 2 nd generation technology, additional in-vitro evolution technology was applied. The Company previously secured the ...
The MarketWatch News Department was not involved in the creation of this content. -- Gram-negative bacterial infections are becoming an increasingly serious global health issue -- U.S. patent ...
Development of Bacteriophages targeting strains causing urinary tract infections Establishment of collaboration with the US Army and investigation of groundwork for entering the US defense market ...
Intron Technology’s 01760 2022 result was driven by strong growth in revenue from electric vehicles and automated vehicles, with consolidated revenue up 52% and net profit up 107%. Together, these two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results